High yield synthesis,structure confirm of acyclovir palmitate and its role in inhibiting hepatitics B in vitro

Qin-sheng CAI,Mei-qing FENG,Hai HUANG,Pei ZHOU

DOI: https://doi.org/10.3969/j.issn.1672-8467.2007.04.003

2007-01-01

Abstract:Purpose To improve the antiHBV activity of acyclovir, its prodrug, acyclovir palmitate, was synthesized. Liposomes of acyclovir palmitate was prepared. Methods Based on acyclovir and palmitoyl chloride, prodrug acyclovir palmitate was synthesized at 60°C for 24 h in pyridine. Furtherly liposomes of acyclovir palmitate was prepared by sodium deoxycholate dialysis. Its ability to inhibit hepatitis B virus HBsAg and HBeAg secretion was studied by a HBV-transfectted cell line (HepG2 2. 2. 15 cells). Results With a yield of 68% acyclovir palmitate was synthesized and its structure was confirmed by Uv-Vis, IR, MS,1 H NMR,13C NMR,D2O exchange NMR, BB-DEPT,1 H - 1 H COSY, 1H- 1HTOCSY, HSQC and HMBC. Liposomes of acyclovir palmitate 61 nm, 20-100 nm. The test reveal that the acyclovir palmitate concentration of liposomes that inhibited HBsAg secreteion by 20. 3%, 52. 6%,68.4%and HBeAg secretion by 29. 3%,42. 4%,and 53.5% at 0. 044 μmol/mL,0. 088 μmol/mL, and 0.222 μmol/mL respectively. Conclusions Acyclovir palmitate was synthesized at 60°C for 24 h in pyridine with a high yield. Liposomes of acyclovir palmitate with 61 nm mean size was prepared by sodium deoxycholate dialysis and its ability to inhibit hepatitis B virus HBsAg and HBeAg secretion better than the parent drug.